ADORA2A and Anxiety: Since the α2A-AR is the most prevalent and widely distributed α2-AR subtype in humans, high selectivity over this target should reduce the potential for peripheral (e.g. cardiovascular) or central (e.g. anxiety) side-effects that are commonly observed with subtype non-selective α2-AR antagonists [12, 13].